Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to -$50000.0.

  • Kewaunee Scientific's Asset Writedowns and Impairment fell 51666.67% to -$50000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $14000.0, marking a year-over-year decrease of 8771.93%. This contributed to the annual value of $68000.0 for FY2025, which is 7536.23% down from last year.
  • Kewaunee Scientific's Asset Writedowns and Impairment amounted to -$50000.0 in Q4 2025, which was down 51666.67% from $19000.0 recorded in Q3 2025.
  • Over the past 5 years, Kewaunee Scientific's Asset Writedowns and Impairment peaked at $125000.0 during Q3 2023, and registered a low of -$52000.0 during Q2 2025.
  • In the last 5 years, Kewaunee Scientific's Asset Writedowns and Impairment had a median value of $21000.0 in 2022 and averaged $24250.0.
  • The largest annual percentage gain for Kewaunee Scientific's Asset Writedowns and Impairment in the last 5 years was 102857.14% (2022), contrasted with its biggest fall of 52000.0% (2022).
  • Kewaunee Scientific's Asset Writedowns and Impairment (Quarter) stood at -$5000.0 in 2021, then plummeted by 520.0% to -$31000.0 in 2022, then skyrocketed by 293.55% to $60000.0 in 2023, then crashed by 80.0% to $12000.0 in 2024, then plummeted by 516.67% to -$50000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$50000.0 in Q4 2025, compared to $19000.0 in Q3 2025 and -$52000.0 in Q2 2025.